glp-1 data Products - Briefs - Number 537 GLP-1 Receptor Agonist Market Size

Based on the findings, the researchers concluded that initiating GLP-1 therapy was associated with a modestly increased risk of fragility fractures in older adults with type 2 diabetes. They indicated the results may help physicians weigh potential skeletal risks against the drugs expected health benefits

We have also secured meaningful results in many product liability cases, including a $4 million settlement in a product liability wrongful death case in Lake County and a $3.15 million product liability settlement , also in Lake County

A warning about compounded semaglutide: the FDA does not approve compounded versions of GLP-1s, and the agency has issued specific warnings about safety risks in 2026

Aberrant Mucin expression profiles associate with pediatric inflammatory bowel disease presentation and activity